Pharmacia Deutschland GmbH

Pharmacia Deutschland GmbH — FDA 510(k) Submissions

Pharmacia Deutschland GmbH has submitted 10 FDA 510(k) premarket notifications since 2002, of which 10 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi), System, Test, Anticardiolipin Immunological, Antinuclear Antibody (enzyme-labeled), Antigen, Controls, Anti-dna Antibody (enzyme-labeled), Antigen, Control, Test System, Antineutrophil Cytoplasmic Antibodies (anca) . Use the specialty filter in the sidebar to narrow results.